Finished Pharmaceutical Products (FPPs) – Page 3

Finished product hardness / friability drift during EMA/MHRA inspection preparation: CAPA plan that inspectors accept (with effectiveness checks and due dates)

Detecting variations in product hardness and friability is crucial during the production process. Some key signals that may indicate a potential issue include:Click to read the full article.

Finished product packaging leakage complaint after method transfer to a new QC lab: FDA-compliant investigation flow and batch disposition decision tree

Identifying the symptoms associated with packaging leakage is the first step in a robust investigation. Symptoms may manifest in various ways, including:Click to read the full article.

Finished product fill weight / volume variability after equipment calibration drift found: FDA-compliant investigation flow and batch disposition decision tree

Identifying symptoms of fill weight or volume variability begins with monitoring production output. Common signals include:Click to read the full article.

Finished product blend uniformity failure during recall risk assessment: manufacturing vs lab root cause mapping and required evidence

Identifying symptoms of a blend uniformity failure is the first critical step in any deviation investigation. Symptoms can manifest in various ways, including:Click to read the full article.

Finished product disintegration failure during complaint trending review: how to build a deviation package that passes an inspection deep-dive

Identifying symptoms associated with finished product disintegration failure is crucial for initiating an effective investigation. Common signals may include:Click to read the full article.

Finished product nitrosamine risk assessment gap after method transfer to a new QC lab: risk assessment for patient impact and field alert / recall triggers

Identifying symptoms or signals is the first step in the investigation process. Common indicators of a nitrosamine risk assessment gap post-method transfer may include:Click to read the full article.

Finished product viscosity drift during recall risk assessment: manufacturing vs lab root cause mapping and required evidence

Identifying symptoms or signals associated with viscosity drift is paramount. These signals may originate from various points in the manufacturing process or the laboratory setting. Key symptoms include:Click to read…

Finished product CCIT failure during CPV annual product review: stability strategy adjustments and packaging risk mitigation steps

Detecting CCIT failures involves observing specific symptoms that may manifest during routine inspections or product tests. Common signals that indicate potential issues include:Click to read the full article.

Finished product microbial limits failure during recall risk assessment: FDA-compliant investigation flow and batch disposition decision tree

When a finished product microbial limits failure occurs, several signals may indicate potential issues:Click to read the full article.

Finished product CCIT failure after equipment calibration drift found: CAPA plan that inspectors accept (with effectiveness checks and due dates)

The first step in understanding CCIT failures is identifying the symptoms or signals that indicate a potential issue. Common signs that may suggest a failure in CCIT due to equipment…

Finished product nitrosamine risk assessment gap after method transfer to a new QC lab: manufacturing vs lab root cause mapping and required evidence

Identifying symptoms or signals during the manufacturing or evaluation phases is essential to trigger an investigation into potential analysis gaps. Some common indicators include:Click to read the full article.

Finished product nitrosamine risk assessment gap during PAI / FDA inspection readiness: risk assessment for patient impact and field alert / recall triggers

The presence of nitrosamines in finished pharmaceutical products can lead to serious regulatory repercussions and potential recalls. Symptoms or signals indicating a gap in nitrosamine risk assessment may include:Click to…